Nod to Serum Institute for trials of Oxford vaccine

IndiaTimes

31 Jul 2020 0 shares 1 views

Nod to Serum Institute for trials of Oxford vaccine

Nod to Serum Institute for trials of Oxford vaccine

IndiaTimes

Published 31 Jul 2020

A subject expert committee on Covid-19 on Friday recommended to the country's drug regulator that permission be granted to Serum Institute of India (SII) for conducting the second and third phases of human clinical trials of the Oxford vaccine candidate.

You might like

Related news coverage

Is Coronavirus Vaccine Made From Fetal Cell Lines?

Is Coronavirus Vaccine Made From Fetal Cell Lines?

Eurasia Review 29 Jul 2020

By Matt Hadro

As coronavirus vaccine prototypes move closer to testing and approval, some Catholics are debating the..

Panel recommends permission to Serum Institute for phase 2, 3 human clinical trials of Oxford vaccine candidate
IndiaTimes 31 Jul 2020
DCGI asks Serum Institute to revise protocol for phase 2, 3 trials of Oxford COVID-19 vaccine
Hindu 30 Jul 2020
Is the coronavirus vaccine made from fetal cell lines?
CNA 28 Jul 2020
India readies five sites for final phase of human trials of Oxford COVID vaccine
Mid-Day 28 Jul 2020

Advertisement

More coverage

Serum Institute of India seeks DCGI permission for phase 2/3 clinical trials of Oxford’s COVID-19 vaccine

Hindu 25 Jul 2020

The Pune-based drug firm submitted its application to the DCGI on Friday seeking permission for conducting the trials of..

Adar Poonawalla: I believe Oxford coronavirus vaccine Covishield will reach masses by 2021 first quarter of
Mid-Day 24 Jul 2020
Oxford University vaccine candidate: Serum Institute hopes to start clinical trials by August, says Adar Poonawalla
Indian Express 22 Jul 2020
Oxford vaccine triggers immune response, safe
Mid-Day 21 Jul 2020
Support grows for deliberately exposing vaccine trial subjects to COVID-19, with Oxford team leading the way
National Post 20 Jul 2020